Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance

Priti Patel, Raymond Balise, Sandy Srinivas

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: The aim of this study was to assess fluctuations in normal serum alpha-fetoprotein (AFP) levels in patients with germ cell cancer. Marked variations occur after serum AFP levels normalize, creating anxiety among patients and physicians during surveillance. Patients and Methods: We conducted a retrospective review of patients with germ cell tumors in clinical remission, who had normal AFP levels and were followed at our center from 1991 to 2009. 72 patients, with a median follow-up of 50 months, were identified. Results: Of the 72 patients, 57 (79%) had a non-seminomatous germ cell histology, and 15 (21%) had seminomas. Seminomas were included as controls as serum AFP levels do not increase in this group. 68 patients underwent orchiectomy, and 50 patients received systemic chemotherapy. The majority of patients (93%) demonstrated fluctuations in serum AFP. There was no difference in the mean AFP values between patients with seminona (2.95 ng/ml) and those with non-seminomatous germ cell tumors (3.3 ng/ml) (standard deviation 1.01 ng/ml). Conclusion: Marked variations occur after serum AFP levels normalize in patients undergoing surveillance. Fluctuating AFP levels within normal limits did not result in relapse in our cohort of patients with extended follow-up.

Original languageEnglish (US)
Pages (from-to)588-591
Number of pages4
JournalOnkologie
Volume35
Issue number10
DOIs
StatePublished - Oct 2012
Externally publishedYes

Fingerprint

Testicular Neoplasms
alpha-Fetoproteins
Serum
Seminoma
Germ Cell and Embryonal Neoplasms
Orchiectomy
Germ Cells
Histology
Anxiety
Physicians

Keywords

  • Chemotherapy
  • Relapse
  • Serum AFP
  • Surveillance

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Hematology

Cite this

Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance. / Patel, Priti; Balise, Raymond; Srinivas, Sandy.

In: Onkologie, Vol. 35, No. 10, 10.2012, p. 588-591.

Research output: Contribution to journalArticle

@article{a09c07d836814e4d9dde85f2fd41b755,
title = "Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance",
abstract = "Background: The aim of this study was to assess fluctuations in normal serum alpha-fetoprotein (AFP) levels in patients with germ cell cancer. Marked variations occur after serum AFP levels normalize, creating anxiety among patients and physicians during surveillance. Patients and Methods: We conducted a retrospective review of patients with germ cell tumors in clinical remission, who had normal AFP levels and were followed at our center from 1991 to 2009. 72 patients, with a median follow-up of 50 months, were identified. Results: Of the 72 patients, 57 (79{\%}) had a non-seminomatous germ cell histology, and 15 (21{\%}) had seminomas. Seminomas were included as controls as serum AFP levels do not increase in this group. 68 patients underwent orchiectomy, and 50 patients received systemic chemotherapy. The majority of patients (93{\%}) demonstrated fluctuations in serum AFP. There was no difference in the mean AFP values between patients with seminona (2.95 ng/ml) and those with non-seminomatous germ cell tumors (3.3 ng/ml) (standard deviation 1.01 ng/ml). Conclusion: Marked variations occur after serum AFP levels normalize in patients undergoing surveillance. Fluctuating AFP levels within normal limits did not result in relapse in our cohort of patients with extended follow-up.",
keywords = "Chemotherapy, Relapse, Serum AFP, Surveillance",
author = "Priti Patel and Raymond Balise and Sandy Srinivas",
year = "2012",
month = "10",
doi = "10.1159/000342695",
language = "English (US)",
volume = "35",
pages = "588--591",
journal = "Oncology Research and Treatment",
issn = "2296-5270",
publisher = "S. Karger AG",
number = "10",

}

TY - JOUR

T1 - Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance

AU - Patel, Priti

AU - Balise, Raymond

AU - Srinivas, Sandy

PY - 2012/10

Y1 - 2012/10

N2 - Background: The aim of this study was to assess fluctuations in normal serum alpha-fetoprotein (AFP) levels in patients with germ cell cancer. Marked variations occur after serum AFP levels normalize, creating anxiety among patients and physicians during surveillance. Patients and Methods: We conducted a retrospective review of patients with germ cell tumors in clinical remission, who had normal AFP levels and were followed at our center from 1991 to 2009. 72 patients, with a median follow-up of 50 months, were identified. Results: Of the 72 patients, 57 (79%) had a non-seminomatous germ cell histology, and 15 (21%) had seminomas. Seminomas were included as controls as serum AFP levels do not increase in this group. 68 patients underwent orchiectomy, and 50 patients received systemic chemotherapy. The majority of patients (93%) demonstrated fluctuations in serum AFP. There was no difference in the mean AFP values between patients with seminona (2.95 ng/ml) and those with non-seminomatous germ cell tumors (3.3 ng/ml) (standard deviation 1.01 ng/ml). Conclusion: Marked variations occur after serum AFP levels normalize in patients undergoing surveillance. Fluctuating AFP levels within normal limits did not result in relapse in our cohort of patients with extended follow-up.

AB - Background: The aim of this study was to assess fluctuations in normal serum alpha-fetoprotein (AFP) levels in patients with germ cell cancer. Marked variations occur after serum AFP levels normalize, creating anxiety among patients and physicians during surveillance. Patients and Methods: We conducted a retrospective review of patients with germ cell tumors in clinical remission, who had normal AFP levels and were followed at our center from 1991 to 2009. 72 patients, with a median follow-up of 50 months, were identified. Results: Of the 72 patients, 57 (79%) had a non-seminomatous germ cell histology, and 15 (21%) had seminomas. Seminomas were included as controls as serum AFP levels do not increase in this group. 68 patients underwent orchiectomy, and 50 patients received systemic chemotherapy. The majority of patients (93%) demonstrated fluctuations in serum AFP. There was no difference in the mean AFP values between patients with seminona (2.95 ng/ml) and those with non-seminomatous germ cell tumors (3.3 ng/ml) (standard deviation 1.01 ng/ml). Conclusion: Marked variations occur after serum AFP levels normalize in patients undergoing surveillance. Fluctuating AFP levels within normal limits did not result in relapse in our cohort of patients with extended follow-up.

KW - Chemotherapy

KW - Relapse

KW - Serum AFP

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=84867265620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867265620&partnerID=8YFLogxK

U2 - 10.1159/000342695

DO - 10.1159/000342695

M3 - Article

C2 - 23038230

AN - SCOPUS:84867265620

VL - 35

SP - 588

EP - 591

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

SN - 2296-5270

IS - 10

ER -